Skip to main content

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors



The development of new adenine base editors (ABE) and adenine-to-thymine/guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications.

The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement.

Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-editing technologies.

The development of new base editors, which can introduce specific base changes, represents a significant step forward. Due to these challenges, there is a growing necessity to develop precise and efficient gene-editing techniques to enhance watermelon breeding and achieve more reliable crop improvements.

Researchers from Northwest A&F University and Northeast Agricultural University have published a study in Horticulture Research, on April 23, 2024, detailing the development of adenine base editors (ABE) and adenine-to-thymine/guanine base editors (AKBE) base editors for watermelon. These editors allow precise genetic modifications, potentially improving crop traits and breeding efficiency.

The study introduces three types of adenine base editors (U-ABE, S-ABE, and R-ABE) and evaluates their efficiency in inducing A:T-to-G substitutions in watermelon genes. Among them, R-ABE demonstrated the highest efficiency, particularly at the A5 position of the target gene.

Additionally, the researchers developed S-AKBE and R-AKBE to achieve A:T-to-T mutations, with S-AKBE showing greater efficiency. The successful editing of the ClFT gene to produce the Y84H mutation resulted in a flowerless phenotype, underscoring the potential of these tools in manipulating flowering time and other traits in watermelon.

The findings reveal that the Rps5A promoter used in R-ABE and R-AKBE significantly enhances editing efficiency. Overall, this study highlights the effectiveness of these base editors in achieving precise genetic modifications, paving the way for improved breeding strategies and trait enhancements in watermelon.

Dr. Xian Zhang from Northwest A&F University commented, "The development of these base editors represents a significant breakthrough in plant genetic engineering. These tools not only enhance our ability to study gene function but also pave the way for more precise and efficient crop improvement strategies."

The implementation of ABE and AKBE base editors opens new avenues for watermelon breeding, allowing for the precise introduction of beneficial traits. Future research will focus on optimizing these tools and exploring additional target genes to further enhance the genetic improvement of watermelon and potentially other crops.



International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt

Comments

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...